Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission

被引：15

作者：

Giuliano, M

Palmisano, L

Galluzzo, CM

Amici, R

Germinario, E

Okong, P

Kituuka, P

Mmirro, F

Magoni, M

Vella, S

机构：

[1] Ist Super Sanita, Virol Lab, I-00161 Rome, Italy

[2] St Francis Nsambya Hosp, Kampala, Uganda

[3] Mulago Hosp, Kampala, Uganda

来源：

AIDS | 2003年 / 17卷 / 10期

关键词：

D O I：

10.1097/00002030-200307040-00022

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Two zidovudine/lamivudine regimens for the prevention of HIV perinatal transmission were studied for the selection of resistance mutations. The M184V mutation was detected one week after delivery in six out of fifty women (12%) who received the regimen prepartum, intrapartum and postpartum, and was no longer present 3 months later. No nucleoside reverse transcriptase inhibitor resistance-associated mutations were detected in 50 women who received zidovudine/lamivudine intrapartum and postpartum only. No association with the risk of perinatal transmission was found.

引用

页码：1570 / 1572

页数：3

共 50 条

[1] Drug resistance is uncommon in pregnant women with low viral loads taking zidovudine monotherapy to prevent perinatal HIV transmission
Larbalestier, N
Mullen, J
O'Shea, S
Cottam, F
Sabin, CA
Chrystie, AL
Welche, J
Zuckerman, M
Hay, P
Rice, P
Taylor, GP
Ruiter, AC
AIDS, 2003, 17 (18) : 2665 - 2667
[2] Perinatal transmission of HIV in women receiving zidovudine - Abstract and commentary
Mofenson, LM
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (06): : 569 - 570
[3] Selection of resistance mutations in children receiving prophylaxis with lamivudine or nevirapine for the prevention of postnatal transmission of HIV
Giuliano, M
Galluzzo, CM
Germinario, EAP
Amici, R
Bassani, L
Dehò, L
Vyankandondera, J
Mmiro, F
Okong, P
Vella, S
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 42 (01) : 131 - 133
[4] Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China
Han, J.
Wang, L.
Jiang, Y.
Zhang, Q.
Fang, L.
Yao, J.
Wang, Q.
INTERNATIONAL JOURNAL OF STD & AIDS, 2009, 20 (04) : 249 - 254
[5] Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)
Eshleman, SH
Mracna, M
Guay, LA
Deseyve, M
Cunningham, S
Mirochnick, M
Musoke, P
Fleming, T
Fowler, MG
Mofenson, LM
Mmiro, F
Jackson, JB
AIDS, 2001, 15 (15) : 1951 - 1957
[6] Risk factors of preterm delivery in HIV-infected pregnant women receiving zidovudine for the prevention of perinatal HIV
Traisathit, Patrinee
Mary, Jean Yves
Le Coeur, Sophie
Thantanarat, Sudanee
Jungpichanvanich, Sivaporn
Pornkitprasarn, Witaya
Gomutbutra, Vorapin
Matanasarawut, Wanmanee
Wannapira, Wiroj
Lallemant, Marc
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2009, 35 (02) : 225 - 233
[7] Adequacy of prenatal care and prescription of zidovudine to prevent perinatal HIV transmission
Lansky, A
Jones, JL
Burkham, S
Reynolds, K
Bohannon, B
Bertolli, J
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (03) : 223 - 227
[8] HIV in pregnant women and prevention of perinatal transmission
Giles, Michelle
MICROBIOLOGY AUSTRALIA, 2015, 36 (04) : 182 - 184
[9] Pregnant Women, HIV, and Clinical Research to Prevent Perinatal Transmission in the 1990s
Rodriguez, Sarah B.
JOURNAL OF CONTEMPORARY HISTORY, 2022, 57 (04) : 878 - 894
[10] Emergence of dual resistance to zidovudine and lamivudine in clinical HIV-1 isolates from patients receiving zidovudine/lamivudine combination therapy
Gass, RJA
Shugarts, D
Young, R
Allen, M
Rosandich, M
Kuritzkes, DR
ANTIVIRAL THERAPY, 1998, 3 (02) : 97 - 102

← 1 2 3 4 5 →